CDSCO approves AstraZeneca’s Dapagliflozin with additional indication for treating CKD and heart…
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalisation for heart failure in adults with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CDSCO approval
CDSCO approves Boehringer Ingelheim’s Jardiance for treating heart failure
It's the first treatment for heart failure with preserved ejection fraction (HFpEF) in India
Hetero receives CDSCO approval to manufacture Sputnik Light vaccine for sale in India
Hetero is the first biopharma company in India to receive Manufacturing and Marketing (M&M) approval for the product…